Scientia Clinical Research
Franziska Loehrer is a distinguished professional in the field of clinical research and quality assurance, currently serving as Director Quality & Deputy CEO at Scientia Clinical Research since November 2016, where responsibilities include overseeing QA and compliance for a pioneering early phase clinical trial facility in New South Wales. As Managing Director at Wahoo Clinical since January 2015, Franziska provides comprehensive clinical operations and regulatory compliance services globally, including in emerging markets. Having an extensive academic background, Franziska served as a Lecturer at the University of New South Wales for over two decades, teaching on the Clinical Development of Medicines. Prior experience includes significant leadership roles at GSK, where responsibilities spanned the operational and scientific management of a phase 1 unit, and a position as Senior Clinical Research Scientist at Novartis Pharma. Franziska holds a PhD in Pharmacy from the University of Basel, complemented by a Swiss Federal Diploma in Pharmacy.
This person is not in any teams
Scientia Clinical Research
Scientia Clinical Research is world-class state of the art clinical trials facility with a focus on first-in-human and first-in patient studies as well as the ability to facilitate later phase trials in oncology, haematology, healthy volunteers and across other therapeutic disciplines. We are located in the Bright Alliance Building with the Nelune Comprehensive Cancer Centre and services of the Sydney Children’s Hospital. It is also co-located in a major research precinct with Prince of Wales Hospital, Royal Hospital for Women, UNSW and the Lowy Cancer Research Centre and is thus in a prime position to translate preclinical research into early phase clinical trials to enhance patient care. We have an on-site laboratory and pharmacy and we will be the first facility in Australia to use an electronic real-time study data collection system.